ConductScience.org, home
CT26
API referenceFor AI assistants

Cell line · CVCL_7254

Papers88

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

1 to 20 of 88

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
PubMed 42999633Immunotargets Ther2026Its Methods give the RRID and name the linePubMed
MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation-Associated Colorectal Cancer by Suppressing the STAT3-CCL2 Axis and TAM-Mediated Immunosuppression.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
In-vitro cytotoxic and pro-apoptotic effects of an Echinococcus granulosus antigen B nanoformulation on CT26 colorectal cancer cells.Front Oncol2026Its Methods give the RRID and name the linePubMed
MIIP Inhibits Colorectal Cancer Progression by Modulating Neutrophils Infiltration and Neutrophil Extracellular Trap Formation.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma.J Immunother Cancer2026Its Methods give the RRID and name the linePubMed
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.J Exp Med2026Its Methods give the RRID and name the linePubMed
GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti-PD-1 Immunotherapy.Can J Gastroenterol Hepatol2026Its Methods give the RRID and name the linePubMed
Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass.Cancer Res2026Its Methods give the RRID and name the linePubMed
Mucosal-associated invariant T cells recognize a tumor-derived metabolite in the DNA synthesis pathway.Front Immunol2026Its Methods give the RRID and name the linePubMed
Temporal Immune and Metabolic Shifts Drive the Anti-Tumor Efficacy of Resiquimod-Loaded Nanoparticles in Peritoneal Carcinomatosis.Adv Healthc Mater2026Its Methods give the RRID and name the linePubMed
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockade.Cell Death Dis2026Its Methods give the RRID and name the linePubMed
Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases.Cell Death Dis2026Its Methods give the RRID and name the linePubMed
Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
ICAM1high Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration.Cancer Res2026Its Methods give the RRID and name the linePubMed
Enhancing Immunotherapeutic Response in Colorectal Cancer with a Neuropilin 1-Targeting Tumor-Penetrating Peptide.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis.Cancer Discov2026Its Methods give the RRID and name the linePubMed
Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site.Eur J Immunol2026Its Methods give the RRID and name the linePubMed
Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.Cell Death Dis2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_7254/papers

API referenceFor AI assistants